| Proteomics: New Developments in Target Discovery. | |
| | |
MedLine Citation:
|
PMID: 12677201 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
The Society for Medicines Research in collaboration with the Biological and Medicinal Chemistry sector of the Royal Society for Chemistry held a meeting on September 19, 2002, in London, United Kingdom to discuss proteomics in drug discovery. The meeting gave the most up-to-date overview of current progress in this new field, the challenges in silico, in vitro and in vivo, together with consideration of the increasing contribution of bioanalysis, bioinformatics and pharmacogenomics. Speakers from Celera Genomics, Oxford GlycoSciences and GlaxoSmithKline, among other companies and institutions, were present. (c) 2002 Prous Science. All rights reserved. |
| | |
Authors:
|
Judit M. Nagy; Katherine A. Brown |
Publication Detail:
|
Type: JOURNAL ARTICLE |
Journal Detail:
|
Title: Drug news & perspectives Volume: 15 ISSN: 0214-0934 ISO Abbreviation: Drug News Perspect. Publication Date: 2002 Nov |
Date Detail:
|
Created Date: 2003-Apr-4 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8809164 Medline TA: Drug News Perspect Country: - |
Other Details:
|
Languages: ENG Pagination: 601-603 Citation Subset: - |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Glial Cells as a Target for the Development of New Therapies for Treating Parkinson's Disease.
Next Document: The History of Thalidomide.